{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:37:52Z","timestamp":1792625872169,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.prp.2019.152549","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T10:37:44Z","timestamp":1566643064000},"page":"152549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Salivary duct carcinoma: A case report of oncocytic variant with possible treatment implications and review of literature"],"prefix":"10.1016","volume":"215","author":[{"given":"Radhika","family":"Sekhri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ortanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Boals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"November\u2013December (6)","key":"10.1016\/j.prp.2019.152549_bib0005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.amjoto.2014.07.007","article-title":"Clinicopathologic study of salivary duct carcinoma and the efficacy of androgen deprivation therapy","volume":"35","author":"Yamamoto","year":"2014","journal-title":"Am. J. Otolaryngol."},{"issue":"1","key":"10.1016\/j.prp.2019.152549_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00301495","article-title":"Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma","volume":"192","author":"Kleinsasser","year":"1968","journal-title":"aArch Klin Exp Ohren Nasen Kehlkopfheilkd."},{"key":"10.1016\/j.prp.2019.152549_bib0015","series-title":"WHO Classification of Head and Neck Tumours","first-page":"173","article-title":"Salivary duct carcinoma","author":"Nagao","year":"2017"},{"issue":"4","key":"10.1016\/j.prp.2019.152549_bib0020","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.31353","article-title":"A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from the Netherlands","volume":"143","author":"Boon","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"November","key":"10.1016\/j.prp.2019.152549_bib0025","article-title":"Expression of PTEN, androgen receptor, HER2\/neu, cytokeratin 5\/6, estrogen receptor-beta, HMGA2, and PLAG1 in salivary duct carcinoma","author":"Liang","year":"2018","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.prp.2019.152549_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.oraloncology.2017.09.008","article-title":"Salivary duct carcinoma: an aggressive salivary gland malignancy with opportunities for targeted therapy","volume":"74","author":"Schmitt","year":"2017","journal-title":"Oral Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.prp.2019.152549_bib0035","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/s12105-013-0456-x","article-title":"Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification","volume":"7","author":"Simpson","year":"2013","journal-title":"Head Neck Pathol."},{"issue":"18","key":"10.1016\/j.prp.2019.152549_bib0040","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","article-title":"Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer","volume":"22","author":"Dalin","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"May (5)","key":"10.1016\/j.prp.2019.152549_bib0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","article-title":"Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression","volume":"39","author":"Williams","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2019.152549_bib0050","series-title":"Recent Advances in Histopathology 22","first-page":"17","article-title":"Carcinomas of the salivary gland","author":"Simpson","year":"2007"},{"issue":"July (1)","key":"10.1016\/j.prp.2019.152549_bib0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0030-4220(94)90120-1","article-title":"Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein","volume":"78","author":"Barnes","year":"1994","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"5","key":"10.1016\/j.prp.2019.152549_bib0060","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/1097-0142(19930901)72:5<1503::AID-CNCR2820720503>3.0.CO;2-K","article-title":"Salivary duct carcinoma","volume":"72","author":"Delgado","year":"1993","journal-title":"Cancer"},{"issue":"June (6)","key":"10.1016\/j.prp.2019.152549_bib0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1309\/RVTP1G0Q727WJUQD","article-title":"Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors","volume":"119","author":"Nasser","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"issue":"January (1)","key":"10.1016\/j.prp.2019.152549_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ajcp\/109.1.75","article-title":"Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma","volume":"109","author":"Wick","year":"1998","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2019.152549_bib0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.rpor.2013.08.006","article-title":"Rare breast tumors: review of the literature","volume":"19","author":"Acevedo","year":"2013","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"April (4)","key":"10.1016\/j.prp.2019.152549_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2559.2003.01600.x","article-title":"Expression of HER-2\/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry","volume":"42","author":"Sk\u00e1lov\u00e1","year":"2003","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.prp.2019.152549_bib0085","first-page":"EC01","article-title":"HER2\/neu testing in 432 consecutive breast cancer cases using FISH and IHC - a comparative study","volume":"11","author":"Eswarachary","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"issue":"November (6)","key":"10.1016\/j.prp.2019.152549_bib0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12282-014-0528-0","article-title":"A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer","volume":"22","author":"Bahreini","year":"2015","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.prp.2019.152549_bib0095","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-09-0238","article-title":"Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance","volume":"16","author":"Williams","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2019.152549_bib0100","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","article-title":"The role of molecular testing in the differential diagnosis of salivary gland carcinomas","volume":"42","author":"Skalova","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2019.152549_bib0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7819-4-54","article-title":"Oncocytic carcinoma of parotid gland: a case report with clinical, immunohistochemical and ultrastructural features","volume":"4","author":"Giordano","year":"2006","journal-title":"World J. Surg. Oncol."},{"issue":"March (2)","key":"10.1016\/j.prp.2019.152549_bib0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6","article-title":"Salivary duct carcinoma: clinical characteristics and treatment strategies","volume":"19","author":"Guzzo","year":"1997","journal-title":"Head Neck"},{"issue":"12","key":"10.1016\/j.prp.2019.152549_bib0115","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"issue":"35","key":"10.1016\/j.prp.2019.152549_bib0120","doi-asserted-by":"crossref","first-page":"59023","DOI":"10.18632\/oncotarget.19812","article-title":"Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification","volume":"8","author":"Takase","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2019.152549_bib0125","first-page":"78","article-title":"Metastatic salivary duct carcinoma in cardiac and pleural effusions: a case report with immunocytochemical analysis for androgen receptor and HER2","volume":"10","author":"Ito","year":"2019","journal-title":"Mol. Clin. Oncol."},{"issue":"December (12)","key":"10.1016\/j.prp.2019.152549_bib0130","doi-asserted-by":"crossref","first-page":"E100","DOI":"10.1002\/hed.25392","article-title":"Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas","volume":"40","author":"Park","year":"2018","journal-title":"Head Neck"},{"issue":"July (3)","key":"10.1016\/j.prp.2019.152549_bib0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semradonc.2012.03.009","article-title":"Biology and management of salivary gland cancers","volume":"22","author":"Adelstein","year":"2012","journal-title":"Semin. Radiat. Oncol."},{"issue":"June (16)","key":"10.1016\/j.prp.2019.152549_bib0140","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1200\/JCO.2010.32.8351","article-title":"Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options","volume":"29","author":"Jaspers","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"January (1)","key":"10.1016\/j.prp.2019.152549_bib0145","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1002\/hed.23383","article-title":"Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy","volume":"36","author":"Soper","year":"2014","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.prp.2019.152549_bib0150","first-page":"ZE04","article-title":"Human epidermal growth factor receptor 2 (HER2\/neu) in salivary gland carcinomas: a review of literature","volume":"9","author":"Alotaibi","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"issue":"August (8)","key":"10.1016\/j.prp.2019.152549_bib0155","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/PAS.0b013e3182880d5a","article-title":"PIK3CA mutations and PTEN loss in salivary duct carcinomas","volume":"37","author":"Griffith","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"January (2)","key":"10.1016\/j.prp.2019.152549_bib0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1078-0432.CCR-12-1842","article-title":"Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment","volume":"19","author":"Nardi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2019.152549_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/810487","article-title":"Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma","volume":"2014","author":"Qiu","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"September (3)","key":"10.1016\/j.prp.2019.152549_bib0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.path.2016.04.002","article-title":"Molecular pathology: predictive, prognostic, and diagnostic markers in salivary gland tumors","volume":"9","author":"Seethala","year":"2016","journal-title":"Surg. Pathol. Clin."},{"issue":"6","key":"10.1016\/j.prp.2019.152549_bib0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0000000000000410","article-title":"Molecular characterization of apocrine salivary duct carcinoma","volume":"39","author":"Chiosea","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"20","key":"10.1016\/j.prp.2019.152549_bib0180","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cncr.30179","article-title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations","volume":"122","author":"Chiosea","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.prp.2019.152549_bib0185","first-page":"ZE04","article-title":"Human epidermal growth factor receptor 2 (HER2\/neu) in salivary gland carcinomas: a review of literature","volume":"9","author":"Alotaibi","year":"2015","journal-title":"J. Clin. Diagn. Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819311094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819311094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T01:27:10Z","timestamp":1568942830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819311094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0344033819311094"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152549","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary duct carcinoma: A case report of oncocytic variant with possible treatment implications and review of literature","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152549"}}